Post-Transplant Recurrence of Neuroendocrine Tumors
#2792
Introduction: Recurrence after liver transplantation (LT) for metastases from NET is observed in 30-50% of cases at 5 years after LT but management is individualized
Aim(s): Aim of this study is to identify factors influencing post-recurrence survival and to define the best treatment according to disease presentation
Materials and methods: Consecutive patients treated at a single Institution for post-LT recurrence of NET were included. Baseline patients’ characteristics, primary tumor data, pre-transplant therapies, post-transplant recurrence and long term outcomes were collected and analyzed
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Monteleone M, Sposito C, Rossi R, Pusceddu S, Coppa J,
Keywords: Liver transplantation, Recurrence, Liver metastases,
To read the full abstract, please log into your ENETS Member account.